Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218348 · ClinicalTrials.gov registry record · Phase 2
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 2
- Development phase
- 186
- Enrollment target
NCT00218348 is a Phase 2 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 186 participants.
The verdict
NCT00218348, a Phase 2 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 186 participants
- Enrollment target
Study Summary
Dextro-amphetamine sulfate is a central nervous system stimulant that increases the release of the neurotransmitter dopamine in the brain. The purpose of this study is to further examine dose ranges of dextro-amphetamine sulfate as a treatment for cocaine dependence.
Interventions
- DRUG Dextro-Amphetamine Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2003-09 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218348
The ClinicalTrials.gov registry entry for NCT00218348 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dextro-Amphetamine Sulfate is the first listed.
NCT00218348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218348 about?
NCT00218348 is a clinical study titled "Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo". Dextro-amphetamine sulfate is a central nervous system stimulant that increases the release of the neurotransmitter dopamine in the brain. The purpose of this study is to further examine dose ranges of dextro-amphetamine sulfate as a treatment for cocaine dependence.
What is the current status of trial NCT00218348?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 186 participants. The study started on 2003-09. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00218348?
The interventions under investigation include: Dextro-Amphetamine Sulfate (DRUG).
Who is sponsoring clinical trial NCT00218348?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.